MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 38 filers reported holding MILESTONE PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 2.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $269,089 | -47.5% | 86,839 | -51.8% | 0.00% | – |
| Q2 2023 | $513,003 | -28.9% | 179,987 | -1.8% | 0.00% | – |
| Q1 2023 | $721,806 | +97573.3% | 183,244 | -1.9% | 0.00% | – |
| Q4 2022 | $739 | -99.9% | 186,725 | +154.8% | 0.00% | – |
| Q3 2022 | $673,000 | +50.2% | 73,274 | -2.7% | 0.00% | – |
| Q2 2022 | $448,000 | +12.8% | 75,346 | +22.0% | 0.00% | – |
| Q1 2022 | $397,000 | +15.1% | 61,743 | +17.4% | 0.00% | – |
| Q4 2021 | $345,000 | +32.7% | 52,578 | +15.5% | 0.00% | – |
| Q3 2021 | $260,000 | 0.0% | 45,517 | -3.6% | 0.00% | – |
| Q2 2021 | $260,000 | +17.1% | 47,200 | +23.2% | 0.00% | – |
| Q1 2021 | $222,000 | +48.0% | 38,316 | +71.4% | 0.00% | – |
| Q4 2020 | $150,000 | – | 22,355 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 2,530,585 | $16,955,000 | 0.73% |
| Ikarian Capital, LLC | 1,836,545 | $12,305,000 | 0.54% |
| Boxer Capital, LLC | 2,477,194 | $16,597,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,315,102 | $28,911,000 | 0.48% |
| RA Capital Management | 2,327,714 | $15,596,000 | 0.22% |
| Orbimed Advisors | 2,493,109 | $16,704,000 | 0.15% |
| PURA VIDA INVESTMENTS, LLC | 450,000 | $3,015,000 | 0.11% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 851,291 | $5,704,000 | 0.08% |
| Anson Funds Management LP | 50,113 | $336,000 | 0.07% |
| Tekla Capital Management LLC | 253,610 | $1,699,000 | 0.06% |